Salahop, Hermisa W.
HRN: 14-34-95 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2025
CEFTRIAXONE 1G (VIAL)
06/12/2025
06/18/2025
IV
2g
OD
CAP-MR
Waiting Final Action